About Author : Saipriya Iyer

Saipriya Iyer

Saipriya Iyer presently works as a content developer for decresearch.com and a couple of similar portals. Having dabbled with the domain of content creation for nearly half a decade, she now boasts of an enviable portfolio, holding substantial experience in penning down pieces related to technology, finance, and a wide spectrum of other industry verticals. A qualified computer engineering graduate from the University of Pune, Saipriya can often be found leveraging her knowledge of software technology and electronics in her write-ups. She can be contacted at- [email protected] | https://twitter.com/saipriya_i/

Contribution By Saipriya Iyer

U.S. FDA officially provides the green signal for Laurus Labs’ TLD

Saipriya Iyer Date: February 05, 2019

U.S. FDA officially provides the green signal for Laurus Labs’ TLD

Reputed India-based pharmaceutical company Laurus Labs has made it to the headlines for having officially received the tentative nod of approval from the United States Food and Drug Administration. The green signal, as per credible reports, has been

Janssen declares unblinded ERLEADA Phase 3 TITAN Study for mCSPC

Saipriya Iyer Date: February 01, 2019

Janssen declares unblinded ERLEADA Phase 3 TITAN Study for mCSPC

The IDMC has recommended that patients in the placebo plus ADT group move forward to the ERLEADA plus ADT treatment. Janssen Pharmaceutica, the renowned subsidiary of pharma major Johnson & Johnson, has announced the Phase 3 TITAN unblinded st

AB InBev & Benson Hill team up to improve sustainable barley varieties

Saipriya Iyer Date: January 29, 2019

AB InBev & Benson Hill team up to improve sustainable barley varieties

AB InBev (Anheuser-Busch InBev), a Belgium-based multinational drink & brewing holdings company, has reportedly partnered with an agricultural technology company Benson Hill Biosystems to develop more sustainable and productive varieties of barle

Novo Nordisk launches type II diabetes treating injection in the UK

Saipriya Iyer Date: January 25, 2019

Novo Nordisk launches type II diabetes treating injection in the UK

The injection works by mimicking the GLP-1 hormone that is usually produced in the gut and reduces blood glucose levels experienced post meal. The EU licensing of the drug is based upon the results of the SUSTAIN clinical trial program.

BASF inaugurates first phase of the new Shanghai antioxidants facility

Saipriya Iyer Date: January 24, 2019

BASF inaugurates first phase of the new Shanghai antioxidants facility

The facility’s first phase consists of the liquid antioxidants, power blending and formgiving units, which are now operational. Reports confirm that German chemicals giant BASF has opened the first phase of its new, world-class antioxidants manu

Waymo to build driverless car manufacturing facility in Michigan

Saipriya Iyer Date: January 23, 2019

Waymo to build driverless car manufacturing facility in Michigan

The facility will create around 400 jobs in the region with plans to begin operation by the end of 2021. Alphabet Inc. owned self-driving car company, Waymo LLC has recently received approval to set up a manufacturing facility in Michigan for buil

French dairy group Lactalis acquires Prabhat Dairy in a $239 mn deal

Saipriya Iyer Date: January 23, 2019

French dairy group Lactalis acquires Prabhat Dairy in a $239 mn deal

The acquisition is expected to help Lactalis lower its dependency on domestic markets in Europe. Prabhat Dairy, a milk-processing company based in India, has recently announced that it will be selling its Maharashtra-based business to the French m